Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Terranella

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Pediatrics|September 12, 2024
Naloxone Dispensing to Youth Ages 10-19: 2017-2022Andrew Terranella, Gery Guy, Christina Mikosz
Infection and Drug Resistance|November 25, 2011
Meningococcal conjugate vaccines: optimizing global impactAndrew Terranella, Amanda Cohn, Thomas Clark
Pediatrics|January 24, 2023
Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States: 2015-2020Andrew Terranella, Gery P Guy, Christina Mikosz
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|October 9, 2025
Opioid Dispensing Trends Among Children and Adolescents Aged ≤ 19 Years in the United States: 2018-2022Ceciley Bly, Gery Guy, Christina Mikosz, et al.
JAMA Pediatrics|August 7, 2023
Out-of-Pocket Costs and Payer Types for Buprenorphine Among US Youth Aged 12 to 19 YearsAndrew Terranella, Gery Guy, Andrea Strahan, et al.
Current Psychiatry Reports|September 12, 2025
Prevention and Management of Opioid use Disorder and Overdose in Adolescents and Young AdultsJustine W Welsh, Snehaa D Krishnan, Andrew Terranella
JAMA|December 23, 2024
Trends in Buprenorphine Dispensing Among Adolescents and Young Adults in the USEileen Lee, S Michaela Rikard, Gery Guy, et al.
JAMA Network Open|May 20, 2025
Substance Use Screening, Brief Intervention, and Referral to Treatment Among Youth-Serving CliniciansKathleen Ragan-Burnett, Lyna Schieber, Andrew Terranella, et al.
JAMA Pediatrics|July 29, 2024
Pattern of Buprenorphine Treatment Retention Among Youth Aged 10 to 18 Years-US, 2015 to 2021Sarah Connolly, Andrew Terranella, Gery P Guy, et al.
American Journal of Preventive Medicine|February 5, 2025
Gabapentinoid Dispensing to Children and Adolescents in the U.SAndrew Terranella, Xinyi Jiang, Ceciley Bly, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Pediatrics|September 12, 2024
Naloxone Dispensing to Youth Ages 10-19: 2017-2022Andrew Terranella, Gery Guy, Christina Mikosz
Infection and Drug Resistance|November 25, 2011
Meningococcal conjugate vaccines: optimizing global impactAndrew Terranella, Amanda Cohn, Thomas Clark
Pediatrics|January 24, 2023
Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States: 2015-2020Andrew Terranella, Gery P Guy, Christina Mikosz
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|October 9, 2025
Opioid Dispensing Trends Among Children and Adolescents Aged ≤ 19 Years in the United States: 2018-2022Ceciley Bly, Gery Guy, Christina Mikosz, et al.
JAMA Pediatrics|August 7, 2023
Out-of-Pocket Costs and Payer Types for Buprenorphine Among US Youth Aged 12 to 19 YearsAndrew Terranella, Gery Guy, Andrea Strahan, et al.
Current Psychiatry Reports|September 12, 2025
Prevention and Management of Opioid use Disorder and Overdose in Adolescents and Young AdultsJustine W Welsh, Snehaa D Krishnan, Andrew Terranella
JAMA|December 23, 2024
Trends in Buprenorphine Dispensing Among Adolescents and Young Adults in the USEileen Lee, S Michaela Rikard, Gery Guy, et al.
JAMA Network Open|May 20, 2025
Substance Use Screening, Brief Intervention, and Referral to Treatment Among Youth-Serving CliniciansKathleen Ragan-Burnett, Lyna Schieber, Andrew Terranella, et al.
JAMA Pediatrics|July 29, 2024
Pattern of Buprenorphine Treatment Retention Among Youth Aged 10 to 18 Years-US, 2015 to 2021Sarah Connolly, Andrew Terranella, Gery P Guy, et al.
American Journal of Preventive Medicine|February 5, 2025
Gabapentinoid Dispensing to Children and Adolescents in the U.SAndrew Terranella, Xinyi Jiang, Ceciley Bly, et al.
Pageof 3